AstraZeneca and TotalEnergies are among the stocks that fell into undervalued territory. We sell different types of products and services to both investment professionals and individual investors ...

Congruence has been awarded the Neuroscience Section Blitz Talk Award for transformative research in MC4R-related early-onset genetic obesity - -Congruence's insights into the biology and ...

Title: "Discovery of Small Molecule Correctors for Treatment of Early-onset MC4R-deficient Genetic Obesity"Poster Number: 065Session Date and Time: 11/3/2024, 7.30pm – 8.30pmPresenting Author ...

today announced two poster presentations at Obesity Week® 2024. In recognition of its innovative research, Congruence has been awarded the Neuroscience Section Blitz Talk Award and will present ...

Viking Therapeutics Inc (NASDAQ:VKTX) announced that new clinical data from the company’s VK2735 obesity program were ...

Congruence is a computationally-driven biotechnology company building a unique pipeline of transformative small molecule correctors rationally designed to rescue aberrant protein function. Our ...

Oct. 30, 2024 — Young people with severe obesity who underwent weight-loss surgery at age 19 or younger continued to see sustained weight loss and resolution of common obesity-related ...

Congruence has been awarded the Neuroscience Section Blitz Talk Award for transformative research in MC4R-related early-onset genetic obesity - -Congruence's insights into the biology and pharmacology ...